Telehealth Growth And Aging Populations Will Expand Glucose Monitoring
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
10 Aug 25
Updated
16 Aug 25
AnalystHighTarget's Fair Value
US$2.00
76.4% undervalued intrinsic discount16 Aug
US$0.47
1Y
14.5%7D
-4.6%